0000950170-24-081603.txt : 20240703 0000950170-24-081603.hdr.sgml : 20240703 20240703170003 ACCESSION NUMBER: 0000950170-24-081603 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240701 FILED AS OF DATE: 20240703 DATE AS OF CHANGE: 20240703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Amin Dipti CENTRAL INDEX KEY: 0001856708 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12830 FILM NUMBER: 241100784 MAIL ADDRESS: STREET 1: C/O LINEAGE CELL THERAPEUTICS, INC. STREET 2: 2173 SALK AVENUE, SUITE 200 CITY: CARLSBAD STATE: CA ZIP: 92008 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Lineage Cell Therapeutics, Inc. CENTRAL INDEX KEY: 0000876343 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 943127919 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2173 SALK AVENUE STREET 2: SUITE 200 CITY: CARLSBAD STATE: CA ZIP: 92008 BUSINESS PHONE: 5105213390 MAIL ADDRESS: STREET 1: 2173 SALK AVENUE STREET 2: SUITE 200 CITY: CARLSBAD STATE: CA ZIP: 92008 FORMER COMPANY: FORMER CONFORMED NAME: BIOTIME INC DATE OF NAME CHANGE: 19930328 4 1 ownership.xml 4 X0508 4 2024-07-01 0000876343 Lineage Cell Therapeutics, Inc. LCTX 0001856708 Amin Dipti C/O LINEAGE CELL THERAPEUTICS 2173 SALK AVENUE, SUITE 200 CARLSBAD CA 92008 true false false false false Stock Option (Right to Buy) 0.9541 2024-07-01 4 A false 75000 0.00 A 2034-07-01 Common Shares 75000 75000 D Will vest and become exercisable on July 1, 2025, subject to the reporting person's continuous service with the issuer. /s/ Alexandra Hernandez, as Attorney-in-Fact 2024-07-03